TY - JOUR
T1 - Reaction of peripheral‐blood lymphocytes to the human chorionic gonadotropin β sub‐unit in patients with productive tumors
AU - Housseau, Frank
AU - Rouas‐Freiss, Nathalie
AU - Benifla, Jean‐Louis ‐L
AU - Marcillac, Isabelle
AU - Roy, Maguy
AU - Troalen, Frédéric
AU - Fernandez, Hervé
AU - Prapotnich, Dominique
AU - Valencien, Guy
AU - Bougaran, Joelle
AU - Cottu, Paul
AU - Culine, Stéphane
AU - Droz, Jean‐Pierre ‐P
AU - Bidart, Jean‐Michel ‐M
AU - Bellet, Dominique
PY - 1995/11/27
Y1 - 1995/11/27
N2 - Human chorionic gonadotropin (hCG) and its β sub‐unit (hCGβ) are secreted by trophoblast cells during pregnancy, and by tumoral cells of trophoblastic and non‐trophoblastic origin. In contrast to hCG, the free hCGβ sub‐unit is consistently undetectable in healthy non‐pregnant subjects. With this in mind, we sought to determine whether an immune response to hCGβ can be detected in patients with bladder or germ‐cell testis cancers. Peripheral‐blood mononuclear cells (PBMC) from 31% of patients with hCGβ‐productive bladder cancers and 33% of testis‐tumor‐bearing patients displayed an hCGβ‐specific proliferative response, whereas no patients with non‐hCGβ‐productive cancers had a proliferative response. PBMC from pregnant women and healthy controls did not elicit significant reactivity. By the use of overlapping synthetic peptides, the immunogenic regions of hCGβ were delineated within the central 20–65 portion. Moreover, in 2 bladder‐cancer patients with the HLA DR7, DQ2 haplotype, the T‐cell response to hCGβ was focused on the hCGβ(20–47) peptide. Taken together, these results indicate that hCGβ is a tumor‐associated antigen capable of inducing a cell‐mediated immune response in patients with productive tumors. © 1995 Wiley‐Liss, Inc.
AB - Human chorionic gonadotropin (hCG) and its β sub‐unit (hCGβ) are secreted by trophoblast cells during pregnancy, and by tumoral cells of trophoblastic and non‐trophoblastic origin. In contrast to hCG, the free hCGβ sub‐unit is consistently undetectable in healthy non‐pregnant subjects. With this in mind, we sought to determine whether an immune response to hCGβ can be detected in patients with bladder or germ‐cell testis cancers. Peripheral‐blood mononuclear cells (PBMC) from 31% of patients with hCGβ‐productive bladder cancers and 33% of testis‐tumor‐bearing patients displayed an hCGβ‐specific proliferative response, whereas no patients with non‐hCGβ‐productive cancers had a proliferative response. PBMC from pregnant women and healthy controls did not elicit significant reactivity. By the use of overlapping synthetic peptides, the immunogenic regions of hCGβ were delineated within the central 20–65 portion. Moreover, in 2 bladder‐cancer patients with the HLA DR7, DQ2 haplotype, the T‐cell response to hCGβ was focused on the hCGβ(20–47) peptide. Taken together, these results indicate that hCGβ is a tumor‐associated antigen capable of inducing a cell‐mediated immune response in patients with productive tumors. © 1995 Wiley‐Liss, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0028848381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028848381&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910630506
DO - 10.1002/ijc.2910630506
M3 - Article
C2 - 7591278
AN - SCOPUS:0028848381
SN - 0020-7136
VL - 63
SP - 633
EP - 638
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 5
ER -